Stroke is the leading cause of long-term disability and preventable disability in the United States. It is also the fifth leading cause of death, killing nearly 130,000 people in the U.S. each year.
Acute ischemic stroke—are hemodynamic variables predictive of outcome after systemic thrombolysis?
Only a third of patients with acute stroke who receive intravenous tissue plasminogen activator (tPA) within 3 h of stroke onset achieve complete recanalization. One reason for a poor response to tPA ...
Angioplasty is now frequently utilized for revascularization in acute stroke patients and is occasionally followed by stenting [56–61] (Figure 2). In most cases, it has been used as a rescue procedure ...
Ultimately, investigators found a significant reduction in ischemic stroke risk with asundexian compared to placebo, both in combination with antiplatelet therapy. Additionally, participants had no ...
Endovascular therapy for acute ischemic stroke is generally avoided when the infarction is large, but the effect of endovascular therapy with medical care as compared with medical care alone for large ...
Larger volume of acute cerebral ischemic lesions is associated with increased risk for stroke or death after endovascular or surgical carotid revascularization, according to new findings. Researchers ...
Please provide your email address to receive an email when new articles are posted on . Intra-arterial alteplase after successful reperfusion with mechanical thrombectomy for large vessel occlusion ...
Ticagrelor may be a more effective antiplatelet therapy than aspirin for the prevention of recurrent stroke and cardiovascular events in patients with acute cerebral ischemia. We conducted an ...
News Medical on MSN
Inflammatory biomarkers offer new insights for precision medicine in ischemic stroke
Ischemic stroke, a leading cause of disability and mortality worldwide, is a complex cerebrovascular event with outcomes ...
Imperative Care, Inc. today announced the presentation of late-breaking, real-world data from a multi-center review of ischemic stroke patients treated with ADAPT 2.0, a next-generation approach to A ...
Intravenous thrombolysis with recombinant tissue plasminogen activator is considered the standard of care in patients with acute ischemic stroke presenting within 4.5 h after onset. Neuroimaging ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results